Differential neuroprotective effects of carnosine, anserine, and N-acetyl carnosine against permanent focal ischemia

Journal of Neuroscience Research

Volumn 86, Issue 13, 2008, Pages 2984-2991

  Min, Jiangyon ^a   Senut, Marie Claude ^a   Rajanikant, Krishnamurthy ^a   Greenberg, Eric ^a   Bandagi, Ram ^a   Zemke, Daniel ^a   Mousa, Ahmad ^a   Kassab, Mounzer ^a   Farooq, Muhammad U ^a   Gupta, Rishi ^a   Majid, Arshad ^a  

^a Michigan State University   (United States)

Author keywords

Anserine; Bestatin; Carnosine; N acetyl carnosine; Permanent cerebral focal ischemia

Indexed keywords

ANSERINE; BESTATIN; CARNOSINE; N ACETYLCARNOSINE; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BRAIN LEVEL; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION;

ANIMALS; ANSERINE; BRAIN ISCHEMIA; CARNOSINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LEUCINE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PROTEASE INHIBITORS; RECOVERY OF FUNCTION;

EID: 57049106761     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21744     Document Type: Article

References (45)

1. Abe F, Schneider M, Black PL, Talmadge JE. 1989. Chemoimmunotheray with cyclophosphamide and bestatin in experimental metastasis in mice. Cancer Immunol Immunother 29:231-236.
2. Biffo S, DeLucia R, Mulatero B, Margolis F, Fasolo A. 1990. Carnosine-,calcitonin gene-related peptide- and tyrosine hydroxylase-immunoreactivity in the mouse olfactory bulb following peripheral denervation. Brain Res 528:353-357.
3. Boldyrev A, Abe H, Stvolinsky S, Tyulina O. 1995. Effects of carnosine and related compounds on generation of free oxygen species: a comparative study. Comp Biochem Physiol 112B:481-485.
4. Boldyrev AA, Stvolinsky SL, Tyulina OV, Koshelev VB, Hori N, Carpenter DO. 1997. Biochemical and physiological evidence that carnosine is an endogenous neuroprotector against free radicals. Cell Mol Neurobiol 17:259-271.
5. Boldyrev A, Song R, Lawrence D, Carpenter DO. 1999. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience 94:571-577.
6. Boldyrev A, Abe H. 1999. Metabolic transformation of neuropeptide carnosine modi.es its biological activity. Cell Mol Neurobiol 19:163-175.
7. Boldyrev AA. 2000. Problems and perspective in studying the biological role of carnosine. Biochem (Mosc) 65:884-890.
8. Boldyrev A, Bulygina E, Leinsoo T, Petrushanko I, Tsubone S, Abe H. 2004. Protection of neuronal cells against reactive oxygen species by carnosine and related compounds. Comp Biochem Physiol 137:81-88.
9. Bonfanti L, Peretto P, Marchis SD, Fasolo A. 1999. Carnosine-related dipeptides in the mammalian brain. Prog Neurobiol 59:333-353.
10. Botbol V, Scornik OA. 1997. Measurement of muscle protein degradation in live mice by accumulation of bestatin-induced peptides. Am J Physiol Endocrinol Metab 273:E1149-E1157.
11. De Marchis S, Melcangi RC, Modena C, Cavaretta I, Peretto P, Agresti C, Fasolo A. 1997. Identification of the glial cell types containing carnosine-related peptides in the rat brains. Neurosci Lett 237:37-40.
12. DeVries AC, Nelson RJ, Traystman RJ, Hurn PD. Cognitive and behavioral assessment in experimental stroke research: will it prove useful? Neurosci Biobehav Rev 25:326-342.
13. Dobrota D, Fedorova T, Stvolinsky S, Babusikova E, Likavcanova K, Drgova A, Strapkova A, Boldyrev A. 2005. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res 30:1283-1288.
14. Dunnett M, Harris RC. 1997. High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatography B 688:47-55.
15. Durukan A, Tatlisumak T. 2007. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behavior 87:179-197.
16. Gallant S, Semyonova M, Yuneva M. 2000. Carnosine as a potential anti-senescence drug. Biochemistry (Mosc) 65:866-868.
17. Garcia J, Wagner S, Liu KF, Hu XJ. 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 26:627-635.
18. Gariballa SE, Sinclair AJ. 2000. Carnosine: physiological properties and therapeutic potential. Age Ageing 29:207-210.
19. Gulewitsch WS, Amiradzibi S. 1900. Uber das carnosine, eine neue organische Bases des Fleischextraktes. Ber Disch Ges 33:1902-1904.
20. Hersh LB, Aboukhair N, Watson S. 1987. Immunohistochemical localization of aminopeptidase M in rat brain and periphery: relationship of enzyme localization and enkephalin metabolism. Peptides 8:523-532.
21. Horning MS, Blakemore LJ, Trombely PQ. 2000. Endogenous mechanisms of neuroprotection: role of zinc, copper, and carnosine. Brain Res 852:56-61.
22. Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, Talmadge JE. 1996. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation. Cancer Immunol Immunother 43:206-212.
23. Jin CL, Yang LX, Wu XH, Li Q, Ding MP, Fan YY, Zhang WP, Luo JH, Chen Z. 2005. Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats. Neuroscience 135:930-947.
24. Kohen R, Yamamoto Y, Cundy K, Ames BN. 1988. Antioxidant activity of carnosine, homocarnosine and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179.
25. Kunze N, Kleinkauf H, Bauer K. 1986. Characterization of two carnosine-degrading enzymes from rat brain: Partial purification and characterization of a carnosinase and a B-alanyl-arginine hydrolase. Eur J Biochem 160:605-613.
26. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP. 2002. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome C release. J Cereb Blood Flow Metab 22:431-443.
27. Lenney JF, George RP, Weiss AM, Kucera CM, Chan PW, Rinzler GS. 1982. Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. Clin Chim Acta 123:221-231.
28. Lo EH, Dalkara T, Moskowitz MA. 2003. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4:399-415.
29. Margolis FL, Grillo M, Brown CE, Williams TH, Pitcher RG, Flgar GJ. 1979. Enzymatic and immunological evidence for two forms of carnosinase in the mouse. Biochim Biophy Acta 570:311-323.
30. Mitsios N, Gaffney J, Kumar P, Krupinski J, Kumar S, Slevin M. 2006. Pathophysiology of acute ischaemic stroke: An analysis of common signalling mechanisms and Identification of new molecular targets. Pathobiology 73:159-175.
31. O'Dowd JJ, Cairns MT, Trainor M, Robins DJ, Miller DJ. 1990. Analysis of carnosine, homocarnosine, and other histidyl derivatives in rat brain. J Neurochem 55:446-452.
32. Otani H, Okumura N, Hashida-Okumura A, Nagai K. 2005. Identification and characterization of a mouse dipeptidase that hydrolyzes L-carnosine. J Biochem (Tokyo) 137:167-175.
33. Peppers SC, Lenney JF. 1988. Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase. Biol Chem Hoppe Seyler 369:1281-1286.
34. Phipps MA. 1991. Assessment of neurological deficits in stroke. Acutecare and rehabilitation implication. Nurs Clin North Am 26:957-910.
35. Rajanikant GK, Zemke D, Senut MC, Frenkel MB, Chen AF, Gupta R, Majid A. 2007. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 38:3023-3031.
36. Reese T, Pórszász P, Baumann D, Bochelen D, Boumezbeur F, McAllister KH, Sauter A, Bjelke B, Rudin M. 2000. Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI. NMR Biomed 13:361-370.
37. Schorlemmer HM, Bosslet K, Sedlacek HH. 1983. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Cancer Res 43:4148-4153.
38. Sekine K, Fujii H, Abe F. 1999. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Leukemia 13:729-734.
39. Stvolinsky SL, Dobrota D. 2000. Anti-ischemic activity of carnosine. Biochemistry 65:998-1005.
40. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. 1990. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293.
41. Tabakman R, Lazarovici P, Kohen R. 2002. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J Neurosci Res 68:463-469.
42. Teufel M, Saudek V, Ledig JP, Bernhard A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D, Ganzhorn AJ, Guenet C, Heintzelmann B, Laucher V, Sauvage C, Smirnova T. 2003. Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278:6521-6531.
43. Trombley PQ, Horning MS, Blakemore LJ. 2000. Interactions between carnosine and zinc and copper: implications for neuromodulation and neuroprotection. Biochemistry (Mosc) 65:807-816.
44. Wishcamper CA, Brooks DM, Douglas CJ, Lurie DI. 2003. Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. Brain Res 974:88-98.
45. Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA. 2007. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J Neurosci 85:740-747.